Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of RNA Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNA Vaccinesmarket, defines the market attractiveness level of RNA Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNA Vaccines industry, describes the types of RNA Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA Vaccines market and the development prospects and opportunities of RNA Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA Vaccines market in Chapter 13.
By Player:
Tiba Biotechnology
BioNTech
CureVac
eTheRNA
Sangamo Therapeutics
Argos Therapeutics
Translate Bio
Ethris
In-Cell-Art
Moderna Therapeutics
By Type:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User:
Infectious Disease
Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNA Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNA Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNA Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNA Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNA Vaccines Market Analysis and Outlook to 2022
-
7.1 Global RNA Vaccines Consumption (2017-2022)
-
7.2 United States RNA Vaccines Consumption (2017-2022)
-
7.3 Europe RNA Vaccines Consumption (2017-2022)
-
7.4 China RNA Vaccines Consumption (2017-2022)
-
7.5 Japan RNA Vaccines Consumption (2017-2022)
-
7.6 India RNA Vaccines Consumption (2017-2022)
-
7.7 South Korea RNA Vaccines Consumption (2017-2022)
8 Region and Country-wise RNA Vaccines Market Analysis and Outlook to 2028
-
8.1 Global RNA Vaccines Consumption Forecast (2022-2028)
-
8.2 United States RNA Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe RNA Vaccines Consumption Forecast (2022-2028)
-
8.4 China RNA Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan RNA Vaccines Consumption Forecast (2022-2028)
-
8.6 India RNA Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea RNA Vaccines Consumption Forecast (2022-2028)
9 Global RNA Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global RNA Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global RNA Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global RNA Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNA Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global RNA Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNA Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNA Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNA Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNA Vaccines Market Competitive Analysis
-
14.1 Tiba Biotechnology
-
14.1.1 Tiba Biotechnology Company Details
-
14.1.2 Tiba Biotechnology RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Tiba Biotechnology RNA Vaccines Product and Service
-
14.2 BioNTech
-
14.2.1 BioNTech Company Details
-
14.2.2 BioNTech RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BioNTech RNA Vaccines Product and Service
-
14.3 CureVac
-
14.3.1 CureVac Company Details
-
14.3.2 CureVac RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CureVac RNA Vaccines Product and Service
-
14.4 eTheRNA
-
14.4.1 eTheRNA Company Details
-
14.4.2 eTheRNA RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 eTheRNA RNA Vaccines Product and Service
-
14.5 Sangamo Therapeutics
-
14.5.1 Sangamo Therapeutics Company Details
-
14.5.2 Sangamo Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sangamo Therapeutics RNA Vaccines Product and Service
-
14.6 Argos Therapeutics
-
14.6.1 Argos Therapeutics Company Details
-
14.6.2 Argos Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Argos Therapeutics RNA Vaccines Product and Service
-
14.7 Translate Bio
-
14.7.1 Translate Bio Company Details
-
14.7.2 Translate Bio RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Translate Bio RNA Vaccines Product and Service
-
14.8 Ethris
-
14.8.1 Ethris Company Details
-
14.8.2 Ethris RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Ethris RNA Vaccines Product and Service
-
14.9 In-Cell-Art
-
14.9.1 In-Cell-Art Company Details
-
14.9.2 In-Cell-Art RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 In-Cell-Art RNA Vaccines Product and Service
-
14.10 Moderna Therapeutics
-
14.10.1 Moderna Therapeutics Company Details
-
14.10.2 Moderna Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Moderna Therapeutics RNA Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNA Vaccines
-
Figure RNA Vaccines Picture
-
Table Global RNA Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNA Vaccines Consumption by Country (2017-2022)
-
Figure United States RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNA Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNA Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Tiba Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Tiba Biotechnology RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiba Biotechnology RNA Vaccines Product and Service
-
Table BioNTech (Foundation Year, Company Profile and etc.)
-
Table BioNTech RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech RNA Vaccines Product and Service
-
Table CureVac (Foundation Year, Company Profile and etc.)
-
Table CureVac RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac RNA Vaccines Product and Service
-
Table eTheRNA (Foundation Year, Company Profile and etc.)
-
Table eTheRNA RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA RNA Vaccines Product and Service
-
Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sangamo Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics RNA Vaccines Product and Service
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics RNA Vaccines Product and Service
-
Table Translate Bio (Foundation Year, Company Profile and etc.)
-
Table Translate Bio RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Translate Bio RNA Vaccines Product and Service
-
Table Ethris (Foundation Year, Company Profile and etc.)
-
Table Ethris RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ethris RNA Vaccines Product and Service
-
Table In-Cell-Art (Foundation Year, Company Profile and etc.)
-
Table In-Cell-Art RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table In-Cell-Art RNA Vaccines Product and Service
-
Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Moderna Therapeutics RNA Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics RNA Vaccines Product and Service
-
